Correction to: Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC) (Vaccines, (2023), 11, 8, (1374), 10.3390/vaccines11081374)

Authors
Category Primary study
JournalVaccines
Year 2024
This article has no abstract
Epistemonikos ID: 10b944c6552cc2373c47ef9594a691351fd5ebe3
First added on: Sep 10, 2024